Drugs Prescribed for Patients suffering from Rheumatoid Arthritis

  • Uncategorized

DrugsPrescribed for Patients suffering from Rheumatoid Arthritis



DrugsPrescribed for Patients suffering from Rheumatoid Arthritis

Rheumatoidarthritis is a disorder that caused chronic inflammation in the smalljoints around patient’s feet and hands. In most cases, the diseaseaffects the lining of the patient’s joints there are also painfulswellings that can result to joints deformity and bone erosion(Larssonetal.,2011).Rheumatoid arthritis is an autoimmune disorder because it occurs whenthe immune system of the patient mistakenly attacks the body tissues.As a result, because the disease causes joints and bones problems,the patient experiences other problems such as skin disease, lungs,eyes, and blood vessel blockage. For this reason patients aresubjected to various drugs that are m4eant to help them relieve pain.

Drugsand treatment

Firstly,it is good to note that there is no cure for rheumatoid arthritis. Asa result, medications are given to reduce pain around the joints andthe inflammations the drugs help in slowing or preventing jointdamages. Firstly, NSAIDs which is an anti-inflammatory drug us isused to relieve and reduce joints inflammations. NSAIDs are made upof ibuprofen and naproxen sodium that are good for relieving pain(Hanetal.,2006).

Secondly,Steroids is a form of medication that is given to patients withRheumatoid arthritis. The steroids include prednisone which aids inreducing pain and inflammation and also slow down the join damages.However, this drug may cause thinning of bones diabetes and abnormalweight loss as side effects to avoid these effects the doctors mayprescribe Corticosteroids to control the acute symptoms.

Thirdly,the patients can be given disease-modifying anti-rheumatic drugs(DNARDS) to slow the growth of the rheumatoid arthritis. These drugsare used to reduce joints and body tissue damages that can causepermanent damage. These include drugs such as Methotrexate,Hydroxychloroquine, Lefluomide, and Sulfasalazine. These drugs maycause side effects such as liver damages and sever lung infections,and bone marrow suppression (Brusetal.,1999).

Howgenetic history impact drug effectiveness on rheumatoid arthritispatient

Thereare a number of risk factors such as gender, genetics, age,ethnicity, and patient’s behavior that influence the effectivenessof the above drugs. The issue is genetics, also referred to as familyhistory, highly impact the effects of the prescribed drugs on apatient suffering from rheumatoid arthritis. According to Alonso-Ruizetal.(2008), if a family member is suffering from rheumatoid arthritis,the siblings or other family members in that lineage are at a highrisk of contracting the disease. The affected party may experiencemore joints inflammations and excessive pain joints which may not becontrollable by the drugs. To avoid side effects such as liverdamages, blood vessel blockage, lungs diseases, and eye problems Iwould advise patients with rheumatic arthritis to avoid excessiveintake of the drugs the drugs should be consumed as per the doctor’sprescriptions.


Alonso-Ruiz,A., Pijoan, J. I., Ansuategui, E., Urkaregi, A., Calabozo, M., &ampQuintana, A. (2008). Tumor necrosis factor alpha drugs in rheumatoidarthritis: systematic review and metaanalysis of efficacy and safety.BMCmusculoskeletal disorders,9(1),52.

Brus,H., van de Laar, M., Taal, E., Rasker, J., &amp Wiegman, O. (1999).Determinants of compliance with medication in patients withrheumatoid arthritis: the importance of self-efficacy expectations.Patienteducation and counseling,36(1),57-64.

Han,C., Robinson, D. W., Hackett, M. V., Paramore, L. C., Fraeman, K. H.,&amp Bala, M. V. (2006). Cardiovascular disease and risk factors inpatients with rheumatoid arthritis, psoriatic arthritis, andankylosing spondylitis. TheJournal of rheumatology,33(11),2167-2172.

Larsson,J., Ekblom, A., Henriksson, K., Lundeberg, T., &amp Theodorsson, E.(2011). Concentration of substance P, neurokinin A, calcitoningene-related peptide, neuropeptide Y and vasoactive intestinalpolypeptide in synovial fluid from knee joints in patients sufferingfrom rheumatoid arthritis. Scandinavianjournal of rheumatology,20(5),326-335.

Close Menu